Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Image credit: Saiful52 - stock.adobe.com

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

ByAnne Gonzales-Luna, PharmD,Glenn S Tillotson PhD, FIDSA

September 15th 2023

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

Anne Gonzales-Luna, PharmD

Articles by Anne Gonzales-Luna, PharmD

Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile Infection

Latest Updated Articles

Trending on Pharmacy Times

GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders

TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation

UConn’s Medical Writing Certificate Program: It’s Just "Write"

Pharmacy Policy Updates for October 2025

OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why